Logo image of AQNB

ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079 (AQNB) Stock Fundamental Analysis

NYSE:AQNB - New York Stock Exchange, Inc. - US0158578080 - Currency: USD

25.93  +0.29 (+1.13%)

Fundamental Rating

3

Overall AQNB gets a fundamental rating of 3 out of 10. We evaluated AQNB against 25 industry peers in the Multi-Utilities industry. While AQNB is still in line with the averages on profitability rating, there are concerns on its financial health. AQNB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year AQNB was profitable.
In the past year AQNB had a positive cash flow from operations.
In multiple years AQNB reported negative net income over the last 5 years.
In the past 5 years AQNB always reported a positive cash flow from operatings.
AQNB Yearly Net Income VS EBIT VS OCF VS FCFAQNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

AQNB has a Return On Assets of -9.49%. This is amonst the worse of the industry: AQNB underperforms 96.00% of its industry peers.
AQNB's Return On Equity of -27.63% is on the low side compared to the rest of the industry. AQNB is outperformed by 96.00% of its industry peers.
AQNB has a Return On Invested Capital of 3.93%. This is comparable to the rest of the industry: AQNB outperforms 52.00% of its industry peers.
AQNB had an Average Return On Invested Capital over the past 3 years of 2.36%. This is in line with the industry average of 3.89%.
The last Return On Invested Capital (3.93%) for AQNB is above the 3 year average (2.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -9.49%
ROE -27.63%
ROIC 3.93%
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
AQNB Yearly ROA, ROE, ROICAQNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

AQNB's Operating Margin of 21.00% is in line compared to the rest of the industry. AQNB outperforms 52.00% of its industry peers.
In the last couple of years the Operating Margin of AQNB has declined.
AQNB has a Gross Margin of 73.47%. This is in the better half of the industry: AQNB outperforms 72.00% of its industry peers.
AQNB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21%
PM (TTM) N/A
GM 73.47%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
AQNB Yearly Profit, Operating, Gross MarginsAQNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AQNB is destroying value.
AQNB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AQNB has more shares outstanding
Compared to 1 year ago, AQNB has an improved debt to assets ratio.
AQNB Yearly Shares OutstandingAQNB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AQNB Yearly Total Debt VS Total AssetsAQNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.41, we must say that AQNB is in the distress zone and has some risk of bankruptcy.
AQNB's Altman-Z score of 1.41 is amongst the best of the industry. AQNB outperforms 100.00% of its industry peers.
AQNB has a Debt/Equity ratio of 1.28. This is a high value indicating a heavy dependency on external financing.
AQNB's Debt to Equity ratio of 1.28 is fine compared to the rest of the industry. AQNB outperforms 64.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Altman-Z 1.41
ROIC/WACC0.56
WACC7%
AQNB Yearly LT Debt VS Equity VS FCFAQNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

AQNB has a Current Ratio of 1.16. This is a normal value and indicates that AQNB is financially healthy and should not expect problems in meeting its short term obligations.
AQNB has a better Current ratio (1.16) than 88.00% of its industry peers.
A Quick Ratio of 0.97 indicates that AQNB may have some problems paying its short term obligations.
AQNB's Quick ratio of 0.97 is amongst the best of the industry. AQNB outperforms 88.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.97
AQNB Yearly Current Assets VS Current LiabilitesAQNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

The earnings per share for AQNB have decreased strongly by -24.49% in the last year.
Measured over the past years, AQNB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.38% on average per year.
The Revenue has grown by 13.38% in the past year. This is quite good.
Measured over the past years, AQNB shows a small growth in Revenue. The Revenue has been growing by 7.38% on average per year.
EPS 1Y (TTM)-24.49%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%0%
Revenue 1Y (TTM)13.38%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%-6.06%

3.2 Future

The Earnings Per Share is expected to grow by 6.99% on average over the next years.
The Revenue is expected to grow by 2.30% on average over the next years.
EPS Next Y-20.16%
EPS Next 2Y-0.53%
EPS Next 3Y0.93%
EPS Next 5Y6.99%
Revenue Next Year-9.57%
Revenue Next 2Y-3.12%
Revenue Next 3Y-0.57%
Revenue Next 5Y2.3%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AQNB Yearly Revenue VS EstimatesAQNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AQNB Yearly EPS VS EstimatesAQNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 70.08, which means the current valuation is very expensive for AQNB.
AQNB's Price/Earnings ratio is rather expensive when compared to the industry. AQNB is more expensive than 92.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of AQNB to the average of the S&P500 Index (26.48), we can say AQNB is valued expensively.
With a Price/Forward Earnings ratio of 70.82, AQNB can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, AQNB is valued expensively inside the industry as 96.00% of the companies are valued cheaper.
The average S&P500 Price/Forward Earnings ratio is at 34.04. AQNB is valued rather expensively when compared to this.
Industry RankSector Rank
PE 70.08
Fwd PE 70.82
AQNB Price Earnings VS Forward Price EarningsAQNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AQNB is valued expensively inside the industry as 96.00% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.13
AQNB Per share dataAQNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.53%
EPS Next 3Y0.93%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.49%, AQNB is a good candidate for dividend investing.
AQNB's Dividend Yield is rather good when compared to the industry average which is at 3.56. AQNB pays more dividend than 84.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, AQNB pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.49%

5.2 History

The dividend of AQNB has a limited annual growth rate of 0.06%.
AQNB has been paying a dividend for over 5 years, so it has already some track record.
AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.06%
Div Incr Years1
Div Non Decr Years4
AQNB Yearly Dividends per shareAQNB Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of AQNB are negative and hence is the payout ratio. AQNB will probably not be able to sustain this dividend level.
AQNB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-20.99%
EPS Next 2Y-0.53%
EPS Next 3Y0.93%
AQNB Yearly Income VS Free CF VS DividendAQNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

25.93

+0.29 (+1.13%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners72.96%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap19.91B
Analysts53.33
Price Target21.01 (-18.97%)
Short Float %0%
Short Ratio0.4
Dividend
Industry RankSector Rank
Dividend Yield 4.49%
Yearly Dividend0.41
Dividend Growth(5Y)0.06%
DP-20.99%
Div Incr Years1
Div Non Decr Years4
Ex-Date06-13 2025-06-13 (0.5475)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.21%
Min EPS beat(2)-25.74%
Max EPS beat(2)42.17%
EPS beat(4)2
Avg EPS beat(4)3.68%
Min EPS beat(4)-25.74%
Max EPS beat(4)42.17%
EPS beat(8)3
Avg EPS beat(8)-2.73%
EPS beat(12)5
Avg EPS beat(12)-3.23%
EPS beat(16)6
Avg EPS beat(16)-2.32%
Revenue beat(2)1
Avg Revenue beat(2)0.35%
Min Revenue beat(2)-4.61%
Max Revenue beat(2)5.31%
Revenue beat(4)1
Avg Revenue beat(4)-1.14%
Min Revenue beat(4)-5.17%
Max Revenue beat(4)5.31%
Revenue beat(8)3
Avg Revenue beat(8)-2.03%
Revenue beat(12)7
Avg Revenue beat(12)0.37%
Revenue beat(16)10
Avg Revenue beat(16)2.48%
PT rev (1m)0.32%
PT rev (3m)10.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.75%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)-0.32%
Revenue NY rev (1m)0.25%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE 70.08
Fwd PE 70.82
P/S 6.61
P/FCF N/A
P/OCF 46.86
P/B 4.24
P/tB 6.02
EV/EBITDA 24.13
EPS(TTM)0.37
EY1.43%
EPS(NY)0.37
Fwd EY1.41%
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)0.55
OCFY2.13%
SpS3.92
BVpS6.11
TBVpS4.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.49%
ROE -27.63%
ROCE 4.97%
ROIC 3.93%
ROICexc 3.95%
ROICexgc 4.44%
OM 21%
PM (TTM) N/A
GM 73.47%
FCFM N/A
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
ROICexc(3y)2.37%
ROICexc(5y)2.33%
ROICexgc(3y)2.6%
ROICexgc(5y)2.56%
ROCE(3y)2.99%
ROCE(5y)2.93%
ROICexcg growth 3Y4.3%
ROICexcg growth 5Y-5.03%
ROICexc growth 3Y4.14%
ROICexc growth 5Y-4.63%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
F-Score5
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Debt/EBITDA 5.61
Cap/Depr 199.46%
Cap/Sales 29.3%
Interest Coverage 1.53
Cash Conversion 39.53%
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 0.97
Altman-Z 1.41
F-Score5
WACC7%
ROIC/WACC0.56
Cap/Depr(3y)213.94%
Cap/Depr(5y)245.17%
Cap/Sales(3y)39.89%
Cap/Sales(5y)45.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.49%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%0%
EPS Next Y-20.16%
EPS Next 2Y-0.53%
EPS Next 3Y0.93%
EPS Next 5Y6.99%
Revenue 1Y (TTM)13.38%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%-6.06%
Revenue Next Year-9.57%
Revenue Next 2Y-3.12%
Revenue Next 3Y-0.57%
Revenue Next 5Y2.3%
EBIT growth 1Y26.92%
EBIT growth 3Y4.45%
EBIT growth 5Y4.06%
EBIT Next Year44.64%
EBIT Next 3Y17.99%
EBIT Next 5YN/A
FCF growth 1Y-3.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.77%
OCF growth 3Y45.17%
OCF growth 5Y-4.65%